Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US0153511094
Ticker ALXN
Company ALEXION PHARMACEUTICALS
Currency $
Price
Aware Investor Index (AII) 0.0004
Recommendation STRONG SELL
P/E 106.71
ROE 3.05 %
Capitalization 29,845,030,000 $
Dividend Yield 0.00 %
P/S 7.22
AII Position 689
P/E Position 698
ROE Position 684
Capitalization Position 275
Dividend Yield Position 592
Sales 4,131,200,000 $
10-Year Average Earnings 279,682,500 $
Shares Outstanding 224,500,000
Equity 9,165,300,000 $
Dividend per Share 0 $
Industry Pharmaceutical
Country United States
ALEXION PHARMACEUTICALS Investor Relations Web Site http://ir.alexion.com/







Sales:

YEAR MONTH AMOUNT
2018 12 4,131,200,000.00 $
2017 12 3,551,100,000.00 $
2016 12 3,084,100,000.00 $
2015 12 2,604,047,000.00 $
2014 12 2,233,733,000.00 $
2013 12 1,551,346,000.00 $
2012 12 1,134,114,000.00 $
2011 12 783,431,000.00 $
2010 12 540,957,000.00 $
2009 12 386,800,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 77,600,000.00 $
2017 12 443,300,000.00 $
2016 12 399,400,000.00 $
2015 12 144,385,000.00 $
2014 12 656,912,000.00 $
2013 12 252,895,000.00 $
2012 12 254,822,000.00 $
2011 12 175,315,000.00 $
2010 12 97,030,000.00 $
2009 12 295,166,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 9,165,300,000.00 $
2017 12 8,893,100,000.00 $
2016 12 8,693,800,000.00 $
2015 12 8,258,616,000.00 $
2014 12 3,302,018,000.00 $
2013 12 2,382,079,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 224,500,000
2017 12 225,400,000
2016 12 226,300,000
2015 12 215,933,000
2014 12 201,623,000
2013 12 199,712,000

 












Bloomberg News for ALEXION PHARMACEUTICALS:



Google News for ALEXION PHARMACEUTICALS:

FinBulletin - 1 day ago
Alexion Pharmaceuticals, Inc. (ALXN): Headwinds and Tailwinds
Price Performance of Alexion Pharmaceuticals, Inc. (ALXN). Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has had quite a remarkable price ...
Nasdaq Click
Zealand Pharma (ZEAL), Alexion Pharma (ALXN) Enter ...
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) and Zealand Pharma A/S (NASDAQ: ZEAL) today announced a collaboration to discover and ...
News Leading (press release)
Tracking the ABR for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
Investors might be interested in how sell-side analysts are viewing shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Taking a peek at ...
The RNS Daily
Alexion Pharmaceuticals (ALXN): This will sum up the whole Scenario
[NASDAQ: ALXN]: On February 21st, 2019, Alexion Pharmaceuticals (NASDAQ:ALXN) opened trading at $129.63 and closed at $127.55 a ...
StreetInsider.com - 18 hours ago
2 Stocks For Surefire Gains: VICI Properties Inc. (VICI), Alexion ...
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares depreciated -0.43% over the last trading period, taking overall 5-day performance up to ...
Seeking Alpha
Alexion Pharma (ALXN) and Affibody Announce Pact to Co-Develop ...
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) and Affibody AB today announced a partnership to co-develop ABY-039 for rare ...
Zeeland Press - 1 hour ago
How A $10K Alexion Pharmaceuticals Investment In 2009 Worked Out
How A $10K Alexion Pharmaceuticals Investment In 2009 Worked Out ... investment in shares of Alexion Pharmaceuticals Inc. (NASD: ALXN) ...
WestNewsNow - 22 Feb 2019
Alexion Pharmaceuticals, Inc. (ALXN) Quant Update as Price Index ...
Investors are keeping a close eye on shares of Alexion Pharmaceuticals, Inc. (ALXN). The stock has a current six month price index of 1.08994.
FinBulletin
As Alexion Pharmaceuticals (ALXN) Shares Rose, Robeco ...
Robeco Institutional Asset Management increased its stake in Alexion Pharmaceuticals Inc (ALXN) by 8.72% based on its latest 2018Q4 ...
Equities.com
Clearbridge Maintains Position in Alexion Pharmaceuticals (ALXN ...
Clearbridge Llc increased its stake in Alexion Pharmaceuticals Inc (ALXN) by 8.7% based on its latest 2018Q4 regulatory filing with the SEC.


Back